Maternal and neonatal outcomes among Chinese women meeting NICE but not IADPSG criteria for gestational diabetes mellitus: A retrospective cohort study

Abstract

In China, gestational diabetes mellitus (GDM) is typically diagnosed using the International Association of Diabetes and Pregnancy Study Groups (IADPSG) criteria. This study retrospectively analyzed 19152 pregnant women who underwent an oral glucose tolerance test between 2015 and 2021, comparing the IADPSG and the National Institute for Health and Care Excellence (NICE) criteria. GDM prevalence was 20.39% (IADPSG) and 23.67% (NICE, P < 0.01), with a moderate diagnostic agreement (κ = 0.59; P < 0.01). Compared with women having normal glucose tolerance (NGT group), women diagnosed with GDM by either the IADPSG (GDM-I) or NICE (GDM-N) criteria had significantly higher risks of adverse outcomes (including gestational hypertension, preeclampsia, preterm delivery, macrosomia, low birth weight, and neonatal jaundice). However, those diagnosed by NICE but not by IADPSG (GDM-NI) showed no significant increase in adverse maternal or neonatal outcomes except for neonatal jaundice. Furthermore, the GDM-NI group had significantly lower rates of several adverse outcomes compared with the GDM-I group. These findings suggest that, under current clinical management where women diagnosed by IADPSG received treatment while those diagnosed only by NICE did not, the IADPSG criteria classified fewer women as having GDM but identified a group with a higher observed risk of several adverse pregnancy outcomes than did the NICE criteria.

Keywords

gestational diabetes mellitus / IADPSG / NICE / incidence / adverse pregnancy outcomes

References

[1] Ye W, Luo C, Huang J, et al. Gestational diabetes mellitus and adverse pregnancy outcomes: Systematic review and meta-analysis[J]. BMJ, 2022, 377: e067946. doi: 10.1136/bmj-2021-067946

[2] International Diabetes Federation. The diabetes atlas[EB/OL]. (2022-01-12)[2025-06-10]. https://www.diabetesatlas.org.

[3] Fadl HE, Ostlund IKM, Magnuson AFK, et al. Maternal and neonatal outcomes and time trends of gestational diabetes mellitus in Sweden from 1991 to 2003[J]. Diabet Med, 2010, 27(4): 436-441. doi: 10.1111/j.1464-5491.2010.02978.x

[4] Liu L, Liu L, Wang J, et al. Differentiation of gestational diabetes mellitus by nuclear magnetic resonance-based metabolic plasma analysis[J]. J Biomed Res, 2021, 35(5): 351-360. doi: 10.7555/JBR.35.20200191

[5] Sweeting A, Wong J, Murphy HR, et al. A clinical update on gestational diabetes mellitus[J]. Endocr Rev, 2022, 43(5): 763-793. doi: 10.1210/endrev/bnac003

[6] Ogurtsova K, da Rocha Fernandes JD, Huang Y, et al. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040[J]. Diabetes Res Clin Pract, 2017, 128: 40-50. doi: 10.1016/j.diabres.2017.03.024

[7] Schneider S, Bock C, Wetzel M, et al. The prevalence of gestational diabetes in advanced economies[J]. J Perinat Med, 2012, 40(5): 511-520. doi: 10.1515/jpm-2012-0015

[8] International Association of Diabetes and Pregnancy Study Groups Consensus Panel, Metzger BE, Gabbe SG, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy[J]. Diabetes Care, 2010, 33(3): 676-682. doi: 10.2337/dc09-1848

[9] Donovan LE, Edwards AL, Savu A, et al. Population-level outcomes with a 2-step approach for gestational diabetes screening and diagnosis[J]. Can J Diabetes, 2017, 41(6): 596-602. doi: 10.1016/j.jcjd.2016.12.010

[10] Duran A, Sáenz S, Torrejón MJ, et al. Introduction of IADPSG criteria for the screening and diagnosis of gestational diabetes mellitus results in improved pregnancy outcomes at a lower cost in a large cohort of pregnant women: The St. Carlos Gestational Diabetes Study[J]. Diabetes Care, 2014, 37(9): 2442-2450. doi: 10.2337/dc14-0179

[11] World Health Organization. Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy: A World Health Organization Guideline[J]. Diabetes Res Clin Pract, 2014, 103(3): 341-363. doi: 10.1016/j.diabres.2013.10.012

[12] American Diabetes Association. Classification and diagnosis of diabetes: Standards of medical care in diabetes-2018[J]. Diabetes Care, 2018, 41(Suppl 1): S13-S27. doi: 10.2337/dc18-S002

[13] Nankervis A, McIntyre HD, Moses R, et al. ADIPS consensus guidelines for the testing and diagnosis of hyperglycaemia in pregnancy in Australia and New Zealand[EB/OL]. (2014-11-01)[2026-06-13]. https://www.adips.org/downloads/2014ADIPSGDMGuidelinesV18.11.2014_000.pdf.

[14] Benhalima K, Mathieu C, Damm P, et al. A proposal for the use of uniform diagnostic criteria for gestational diabetes in Europe: An opinion paper by the European Board & College of Obstetrics and Gynaecology (EBCOG)[J]. Diabetologia, 2015, 58(7): 1422-1429. doi: 10.1007/s00125-015-3615-7

[15] Obstetrics Subgroup, Chinese Society of Obstetrics and Gynecology, Chinese Medical Association Group of Pregnancy with Diabetes Mellitus, Chinese Society of Perinatal Medicine, Chinese Medical Association. Diagnosis and therapy guideline of pregnancy with diabetes mellitus[J]. Chin J Obstet Gynecol, 2014, 49(8): 561-569. doi: 10.3760/cma.j.issn.0529-567X.2014.08.001

[16] Wang C, Juan J, Yang H. A summary of Chinese guidelines on diagnosis and management of hyperglycemia in pregnancy (2022)[J]. Matern Fetal Med, 2023, 5(1): 4-8. doi: 10.1097/FM9.0000000000000181

[17] Vince K, Perković P, Matijević R. What is known and what remains unresolved regarding gestational diabetes mellitus (GDM)[J]. J Perinat Med, 2020, 48(8): 757-763. doi: 10.1515/jpm-2020-0254

[18] Bashir M, Ibrahim I, Eltaher F, et al. Screening pregnant women in a high-risk population with WHO-2013 or NICE diagnostic criteria does not affect the prevalence of gestational diabetes[J]. Sci Rep, 2021, 11(1): 5604. doi: 10.1038/s41598-021-84918-y

[19] Todi S, Sagili H, Kamalanathan SK. Comparison of criteria of International Association of Diabetes and Pregnancy Study Groups (IADPSG) with National Institute for Health and Care Excellence (NICE) for diagnosis of gestational diabetes mellitus[J]. Arch Gynecol Obstet, 2020, 302(1): 47-52. doi: 10.1007/s00404-020-05564-9

[20] Jacklin PB, Maresh MJ, Patterson CC, et al. A cost-effectiveness comparison of the NICE 2015 and WHO 2013 diagnostic criteria for women with gestational diabetes with and without risk factors[J]. BMJ Open, 2017, 7(8): e016621. doi: 10.1136/bmjopen-2017-016621

[21] Goyal A, Gupta Y, Tandon N. Overt diabetes in pregnancy[J]. Diabetes Ther, 2022, 13(4): 589-600. doi: 10.1007/s13300-022-01210-6

[22] Ryan EA, Savu A, Yeung RO, et al. Elevated fasting vs post-load glucose levels and pregnancy outcomes in gestational diabetes: A population-based study[J]. Diabet Med, 2020, 37(1): 114-122. doi: 10.1111/dme.14173

[23] Balke S, Weid P, Fangmann L, et al. Glucose levels of the oral glucose tolerance test (oGTT) can predict adverse pregnancy outcomes in women with gestational diabetes (GDM)[J]. J Clin Med, 2023, 12(11): 3709. doi: 10.3390/jcm12113709

[24] Nguyen CL, Lee AH, Minh Pham N, et al. Prevalence and pregnancy outcomes of gestational diabetes mellitus by different international diagnostic criteria: A prospective cohort study in Vietnam[J]. J Matern Fetal Neonatal Med, 2020, 33(21): 3706-3712. doi: 10.1080/14767058.2019.1583733

[25] He Y, Ma RCW, McIntyre HD, et al. Comparing IADPSG and NICE diagnostic criteria for GDM in predicting adverse pregnancy outcomes[J]. Diabetes Care, 2022, 45(9): 2046-2054. doi: 10.2337/dc22-0579

[26] Goyal A, Gupta R, Gupta A, et al. Agreement and disagreement between diagnostic criteria for gestational diabetes and implications for clinical practice: A retrospective observational study[J]. Diabetes Metab Syndr, 2025, 19(2): 103207. doi: 10.1016/j.dsx.2025.103207

[27] Adam S, Rheeder P. Screening for gestational diabetes mellitus in a South African population: Prevalence, comparison of diagnostic criteria and the role of risk factors[J]. S Afr Med J, 2017, 107(6): 523-527. doi: 10.7196/SAMJ.2017.v107i6.12043

[28] Djelmis J, Pavić M, Kotori VM, et al. Prevalence of gestational diabetes mellitus according to IADPSG and NICE criteria[J]. Int J Gynecol Obstet, 2016, 135(3): 250-254. doi: 10.1016/j.ijgo.2016.07.005

[29] O'Malley EG, Reynolds CME, O'Kelly R, et al. The diagnosis of gestational diabetes mellitus (GDM) using a 75 g oral glucose tolerance test: A prospective observational study[J]. Diabetes Res Clin Pract, 2020, 163: 108144. doi: 10.1016/j.diabres.2020.108144

[30] Kariniemi K, Vääräsmäki M, Männistö T, et al. Neonatal outcomes according to different glucose threshold values in gestational diabetes: A register-based study[J]. BMC Pregnancy Childbirth, 2024, 24(1): 271. doi: 10.1186/s12884-024-06473-4

[31] Gorban de Lapertosa S, Sucani S, Salzberg S, et al. Prevalence of gestational diabetes mellitus in Argentina according to the Latin American Diabetes Association (ALAD) and International Association of Diabetes and Pregnancy Study Groups (IADPSG) diagnostic criteria and the associated maternal-neonatal complications[J]. Health Care Women Int, 2021, 42(4-6): 636-656. doi: 10.1080/07399332.2020.1800012

[32] Meek CL, Lewis HB, Patient C, et al. Diagnosis of gestational diabetes mellitus: Falling through the net[J]. Diabetologia, 2015, 58(9): 2003-2012. doi: 10.1007/s00125-015-3647-z

[33] Billionnet C, Mitanchez D, Weill A, et al. Gestational diabetes and adverse perinatal outcomes from 716, 152 births in France in 2012[J]. Diabetologia, 2017, 60(4): 636-644. doi: 10.1007/s00125-017-4206-6

[34] Bogdanet D, Egan A, Reddin C, et al. ATLANTIC DIP: Despite insulin therapy in women with IADPSG diagnosed GDM, desired pregnancy outcomes are still not achieved. What are we missing?[J]. Diabetes Res Clin Pract, 2018, 136: 116-123. doi: 10.1016/j.diabres.2017.12.003

[35] Gupta Y, Goyal A, Ambekar S, et al. Postpartum glycemic and cardiometabolic profile of women testing positive for gestational diabetes mellitus by International Association of Diabetes and Pregnancy Study Groups (IADPSG) but negative by alternate criteria: Insights from CHIP-F study[J]. Diabetes Metab Syndr, 2024, 18(6): 103064. doi: 10.1016/j.dsx.2024.103064